乳腺癌MR功能代谢成像及分子成像研究进展

被引:3
作者
李绪斌 [1 ]
杜湘珂 [2 ]
叶兆祥 [1 ]
机构
[1] 天津医科大学附属肿瘤医院放射科天津市“肿瘤防治”重点实验室乳腺癌防治教育部重点实验室
[2] 北京大学人民医院放射科
关键词
乳腺癌; 磁共振成像; 功能成像; 分子成像;
D O I
暂无
中图分类号
R737.9 [乳腺肿瘤];
学科分类号
摘要
尽管各种MR功能代谢成像和分子成像技术在乳腺癌的早期诊断、鉴别诊断和疗效评估方面的独特作用已得到多数研究者的认同,但因其成像原理的不同,这些乳腺MR成像技术各有其优缺点,故应根据具体情况和技术条件加以选择和组合,以提高乳腺癌的诊断准确率。综述乳腺癌的各种MR功能代谢成像和分子成像的研究进展,重点分析成像技术的临床应用价值及局限性,以期对乳腺癌病人MR成像序列的选择和组合进行有益提示。
引用
收藏
页码:45 / 47
页数:3
相关论文
共 7 条
  • [1] MR molecular imaging of HER-2 in a murine tumor xenograft by SPIO labeling of anti-HER-2 affibody
    Kinoshita, Manabu
    Yoshioka, Yoshichika
    Okita, Yoshiko
    Hashimoto, Naoya
    Yoshimine, Toshiki
    [J]. CONTRAST MEDIA & MOLECULAR IMAGING, 2010, 5 (01) : 18 - 22
  • [2] Nanomedicine: Perspective and promises with ligand-directed molecular imaging[J] . Dipanjan Pan,Gregory M. Lanza,Samuel A. Wickline,Shelton D. Caruthers.European Journal of Radiology . 2009 (2)
  • [3] Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion
    Marini, C.
    Iacconi, C.
    Giannelli, M.
    Cilotti, A.
    Moretti, M.
    Bartolozzi, C.
    [J]. EUROPEAN RADIOLOGY, 2007, 17 (10) : 2646 - 2655
  • [4] Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography
    Yoshikawa M.I.
    Ohsumi S.
    Sugata S.
    Kataoka M.
    Takashima S.
    Kikuchi K.
    Mochizuki T.
    [J]. Radiation Medicine, 2007, 25 (5): : 218 - 223
  • [5] MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents[J] . Martin A Funovics,Barbara Kapeller,Christoph Hoeller,Henry S Su,Rainer Kunstfeld,Stephan Puig,Karin Macfelda.Magnetic Resonance Imaging . 2004 (6)
  • [6] MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles
    Artemov, D
    Mori, N
    Okollie, B
    Bhujwalla, ZM
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (03) : 403 - 408
  • [7] Molecular and functional imaging of breast cancer .2 Glunde K,Jacobs MA,Pathak AP,et al. NMR Biomed . 2009